Grifols (GIFLF) Change in Inventory (2010 - 2025)
Grifols' (GIFLF) quarterly Change in Inventory came in at -$112.9 million in Q4 2025, up 74.47% quarter-over-quarter from -$442.2 million in Q4 2023.
Analysis
Grifols (GIFLF) Change in Inventory (2010 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Change in Inventory for 14 consecutive years, with -$112.9 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory changed N/A year-over-year to -$112.9 million; the trailing twelve-month figure through Dec 2025 stood at -$1.3 billion (changed N/A YoY), and the FY2025 full-year result was -$109.6 million, down 494.45% from the prior year.
- Change in Inventory climbed to -$112.9 million in Q4 2025 per GIFLF's latest filing, from -$442.2 million in the prior quarter.
- Across five years, Change in Inventory topped out at -$112.9 million in Q4 2025 and bottomed at -$643.9 million in Q4 2022.
- Historically, Change in Inventory has averaged -$399.7 million across 3 years, with a median of -$442.2 million in 2023.
- The widest YoY moves for Change in Inventory: up 31.32% in 2023, down 31.32% in 2023.
- Over 3 years, Change in Inventory stood at -$643.9 million in 2022, then jumped by 31.32% to -$442.2 million in 2023, then surged by 74.47% to -$112.9 million in 2025.
- According to Business Quant data, Change in Inventory over the past three periods registered -$112.9 million, -$442.2 million, and -$643.9 million for Q4 2025, Q4 2023, and Q4 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 31.00 Mn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 145.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 27.70 Mn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 28.20 Mn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 132.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | -280,000.00 |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -75.70 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -112.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -112.91 Mn |
| Dec 31, 2023 | -442.21 Mn |
| Dec 31, 2022 | -643.90 Mn |
| Mar 31, 2020 | -82.45 Mn |
| Dec 31, 2019 | -280.06 Mn |
| Mar 31, 2019 | -150.30 Mn |
| Dec 31, 2018 | 206.94 Mn |
| Jun 30, 2018 | -266.03 Mn |
| Mar 31, 2018 | 103.03 Mn |
| Dec 31, 2017 | 127.65 Mn |
| Jun 30, 2017 | 4.76 Mn |
| Mar 31, 2017 | 63.80 Mn |
| Dec 31, 2016 | -29.63 Mn |
| Sep 30, 2016 | -301.49 Mn |
| Dec 31, 2015 | -220.56 Mn |
| Sep 30, 2015 | 26.69 Mn |
| Jun 30, 2015 | 105.84 Mn |
| Mar 31, 2015 | -44.28 Mn |
| Dec 31, 2014 | 32.37 Mn |
| Sep 30, 2014 | 94.38 Mn |